December 23, 2025

The “One Shot” Cure? How Vyriad’s $85M Raise Could Replace Complex CAR-T Labs with a Single Injection

Vyriad, Inc. has secured the final $25M of its Series B financing, bringing the total round to $85M led by Mr. Harry Stine of Stine Seed Farms, Inc.